Unité de Fabrication des Médicaments S.A (BVMT:UMED)

Tunisia · Delayed Price · Currency is TND

9.98

+0.03 (0.30%)

At close: Jun 25, 2026

23.51% (1Y)

Market Cap	319.36M +34.9%
Revenue (ttm)	148.91M +0.8%
Net Income	18.60M -4.0%
EPS	0.58 -4.0%
Shares Out	32.00M
PE Ratio	17.17
Forward PE	18.83
Dividend	0.57 (5.71%)
Ex-Dividend Date	Sep 9, 2026

Volume	16,480
Open	9.94
Previous Close	9.95
Day's Range	9.90 - 9.98
52-Week Range	7.90 - 10.30
Beta	0.18
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 26, 2026

About BVMT:UMED

Unité de Fabrication des Médicaments S.A. develops, manufactures, markets, and sells generic and fashioned medicines in Tunisia and internationally. The company offers ophthalmic, ENT, inhalation and infusion solutions, injectable fluids and penicillin, and cephalosporin powders for various therapeutic areas under the UNIMED brand name. It exports its products to Africa, Asia, and Europe. The company was founded in 1989 and is headquartered in Sousse, Tunisia. [Read more]

Industry Pharmaceutical Preparations

Founded 1989

Employees 572

Stock Exchange Tunis Stock Exchange

Ticker Symbol UMED

Full Company Profile

Financial Performance

In 2025, BVMT:UMED's revenue was 148.91 million, an increase of 0.84% compared to the previous year's 147.68 million. Earnings were 18.60 million, a decrease of -3.98%.

Financial Statements